TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ROUSES POINT PHARMS

Pharmaceuticals
Generics

ROUSES POINT PHARMS is a generic drug manufacturer with 1 FDA-approved products.

2012
Since
1
Drugs
-
Trials
114
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

LEVETIRACETAM 2025-12-02
LEVETIRACETAM 2025-11-21
LEVETIRACETAM 2025-08-15
Labeling
LEVETIRACETAM 2025-08-15
Labeling
LEVETIRACETAM 2025-08-12
Labeling
LEVETIRACETAM 2025-08-12
Labeling
LEVETIRACETAM 2025-08-12
Labeling
LEVETIRACETAM 2025-08-06
Labeling
LEVETIRACETAM 2025-07-09
Labeling
LEVETIRACETAM 2025-04-04
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...